Effectiveness, safety, and tolerability of delayed dexamethasone, rituximab, and cyclophosphamide as first-line treatment in patients with Waldenström macroglobulinemia: data from the Sicilian Myeloma Network - Del Fabro, Vittorio; Markovic, Uros; Frazzetto, Sara; Sciortino, Roberta; Bellofiore, Claudia; Di Giorgio, Mary Ann; Leotta, Valerio; Bulla, Anna; Pelle, Angelo Curto; Elia, Federica; Mannina, Donato; Consoli, Ugo; et al. (Frontiers in Hematology, 2024)